BXMT vs GILD · P/E 30, $3.01B cap vs P/E 18, rev $7.80B
Blackstone Mortgage Trust Inc (BXMT) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Blackstone Mortgage Trust Inc (BXMT) is a reit - mortgage company listed on NYSE.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
BXMT does not have a complete income-statement cache yet.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
BXMT currently screens at market cap $3.01B and trailing P/E 29.7. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the BXMT and GILD stock pages for the full models.
Not investment advice.